Kurt Rasmussen

Kurt Rasmussen

Company: Delix Therapeutics

Job title: CSO

Seminars:

Live Q&A 10:50 am

Read more

day: Day One

Substance Use Disorders as a Lifecycle Play for Neuropsychiatric Drugs 9:10 am

• How can we explore additional indications for Substance Use Disorders for drugs already in development for depression, schizophrenia, anxiety, insomnia, and the neuropsychiatric symptoms of Alzheimer’s Disease? • Evaluating current approaches being developed for Stimulant (methamphetamine and cocaine) Use DisorderRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.